MODERATELY SEVERE OSTEOGENESIS IMPERFECTA ASSOCIATED WITH SUBSTITUTIONS OF SERINE FOR GLYCINE IN THE ALPHA-1(I) CHAIN OF TYPE-I COLLAGEN

被引:5
作者
MARINI, JC
LEWIS, MB
CHEN, K
机构
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 1993年 / 45卷 / 02期
关键词
MOLECULAR PATHOGENESIS; COL1A1; OSTEOGENESIS IMPERFECTA;
D O I
10.1002/ajmg.1320450217
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have examined the type I collagen protein, RNA, and cDNA of 2 children with moderately severe (type IV) osteogenesis imperfecta (OI). They have in common a non-lethal form of OI with ambulatory potential, over-modification of type I collagen protein, and a substitution of serine for glycine in the collagen chain produced by one alpha1(I) allele. The first child (Marini et al.: J Biol Chem 264:11893-11900,1989) is now 7 years old, with the height of a 3-year-old. Her course includes significant remodeling of lower long bones and 4 femur fractures. She walks independently. A mishmatch was detected in her alpha1(I) mRNA using RNA/RNA hybrids; it was demonstrated to be due to a G-->A point mutation in one allele of alpha1(I), resulting in the substitution of serine for glycine 832. The second child is now 6 1/2 years old, with the height of 1 1/2-year-old. Her history includes significant bowing of femurs and tibias, 6 femur fractures, S-curve scoliosis, compression of all lumbar vertebrae, and limited short-distance walking with braces. Her alpha1(I) mRNA has also been studied by RNA hybrid analysis; there is a single G-->A change in one alpha1(I) allele causing the substitution of serine for gly 352. Both children have moderately severe OI. However, the serine substitution at gly 352 is associated with a more severe phenotype then is the serine substitution at gly 832. Compared to substitutions described in other cases of OI, the serine 352 is located in the middle of a cluster of cysteine substitutions associated with non-lethal OI. The ser 832 is located near another non-lethal substitution of serine for glycine but is otherwise flanked by lethal substitutions. These data support a model of OI cause in which crucial and non-crucial regions are interspersed along the type I collagen chain. Whether a mutation located in a particular region causes OI type II or OI type IV would then depend on the importance of that region for the interaction of type I collagen with other matrix components or for intracellular processing.
引用
收藏
页码:241 / 245
页数:5
相关论文
共 10 条
[1]  
BALDWIN CT, 1988, COLLAGEN REL RES, V8, P503
[2]  
BONADIO J, 1985, J BIOL CHEM, V260, P1734
[3]   DETECTION OF POINT MUTATIONS IN TYPE-I COLLAGEN BY RNASE DIGESTION OF RNA RNA HYBRIDS [J].
GRANGE, DK ;
GOTTESMAN, GS ;
LEWIS, MB ;
MARINI, JC .
NUCLEIC ACIDS RESEARCH, 1990, 18 (14) :4227-4236
[4]  
LAMANDE SR, 1989, J BIOL CHEM, V264, P15809
[5]  
MARINI JC, 1989, J BIOL CHEM, V264, P19694
[6]  
RAO VH, 1989, J BIOL CHEM, V264, P1793
[7]   ENZYMATIC AMPLIFICATION OF BETA-GLOBIN GENOMIC SEQUENCES AND RESTRICTION SITE ANALYSIS FOR DIAGNOSIS OF SICKLE-CELL ANEMIA [J].
SAIKI, RK ;
SCHARF, S ;
FALOONA, F ;
MULLIS, KB ;
HORN, GT ;
ERLICH, HA ;
ARNHEIM, N .
SCIENCE, 1985, 230 (4732) :1350-1354
[8]   OSTEOGENESIS IMPERFECTA - THE POSITION OF SUBSTITUTION FOR GLYCINE BY CYSTEINE IN THE TRIPLE HELICAL DOMAIN OF THE PRO-ALPHA-1(I) CHAINS OF TYPE-I COLLAGEN DETERMINES THE CLINICAL PHENOTYPE [J].
STARMAN, BJ ;
EYRE, D ;
CHARBONNEAU, H ;
HARRYLOCK, M ;
WEIS, MA ;
WEISS, L ;
GRAHAM, JM ;
BYERS, PH .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1206-1214
[9]   ANOMALOUS CYSTEINE IN TYPE-I COLLAGEN - LOCALIZATION BY CHEMICAL CLEAVAGE OF THE PROTEIN USING 2-NITRO-5-THIOCYANOBENZOIC ACID AND BY MISMATCH ANALYSIS OF CDNA HETERODUPLEXES [J].
TENNI, R ;
ROSSI, A ;
VALLI, M ;
MOTTES, M ;
PIGNATTI, PF ;
CETTA, G .
MATRIX, 1990, 10 (01) :20-26
[10]  
WENSTRUP RJ, 1988, J BIOL CHEM, V263, P7734